Rock Springs Capital Management LP Pacira Bio Sciences, Inc. Transaction History

Rock Springs Capital Management LP

$2.94 Billion
Q3 2024

A detailed history of Rock Springs Capital Management LP transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 400,000 shares of PCRX stock, worth $7.59 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

400,000

Previous 785,000 49.04%

Holding current value

$7.59 Million

Previous $22.5 Million 73.18%

% of portfolio

0.21%

Previous 0.7%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$11.7 - $28.46 $4.5 Million - $11 Million	-385,000 Reduced 49.04%	400,000 $6.02 Million
Q2 2024 Aug 14, 2024	SELL	$25.5 - $31.51 $6.9 Million - $8.52 Million	-270,500 Reduced 25.63%	785,000 $22.5 Million
Q3 2023 Nov 14, 2023	BUY	$30.68 - $40.09 $628,940 - $821,845	20,500 Added 1.98%	1,055,500 $32.4 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $47.5 $86,688 - $114,000	2,400 Added 0.23%	1,035,000 $41.5 Million
Q4 2022 Feb 14, 2023	BUY	$38.19 - $57.45 $576,669 - $867,495	15,100 Added 1.48%	1,032,600 $39.9 Million
Q2 2022 Aug 15, 2022	BUY	$51.49 - $81.64 $901,075 - $1.43 Million	17,500 Added 1.75%	1,017,500 $59.3 Million
Q3 2021 Nov 15, 2021	SELL	$54.64 - $61.3 $1.37 Million - $1.53 Million	-25,000 Reduced 2.44%	1,000,000 $56 Million
Q4 2020 Feb 16, 2021	BUY	$50.47 - $66.26 $1.01 Million - $1.33 Million	20,000 Added 1.99%	1,025,000 $61.3 Million
Q3 2020 Nov 16, 2020	BUY	$51.97 - $63.0 $4.16 Million - $5.04 Million	80,000 Added 8.65%	1,005,000 $60.4 Million
Q2 2020 Aug 14, 2020	BUY	$30.8 - $52.47 $770,000 - $1.31 Million	25,000 Added 2.78%	925,000 $48.5 Million
Q1 2020 May 15, 2020	SELL	$28.4 - $50.7 $7.1 Million - $12.7 Million	-250,000 Reduced 21.74%	900,000 $30.2 Million
Q3 2019 Nov 14, 2019	SELL	$35.66 - $44.99 $3.57 Million - $4.5 Million	-100,000 Reduced 8.0%	1,150,000 $43.8 Million
Q4 2018 Feb 14, 2019	SELL	$41.31 - $52.16 $1.75 Million - $2.22 Million	-42,479 Reduced 3.29%	1,250,000 $53.8 Million
Q3 2018 Nov 14, 2018	BUY	$32.85 - $52.0 $3.1 Million - $4.91 Million	94,479 Added 7.89%	1,292,479 $63.5 Million
Q2 2018 Aug 14, 2018	BUY	$27.5 - $39.8 $2.01 Million - $2.91 Million	73,000 Added 6.49%	1,198,000 $38.4 Million
Q1 2018 May 15, 2018	BUY	$29.98 - $46.35 $548,634 - $848,205	18,300 Added 1.65%	1,125,000 $35 Million
Q4 2017 Feb 14, 2018	BUY	$31.85 - $46.95 $595,595 - $877,965	18,700 Added 1.72%	1,106,700 $50.5 Million
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $38.8 Million - $43 Million	1,088,000	1,088,000 $40.9 Million

Others Institutions Holding PCRX

# of Institutions

263

Shares Held

50.4M

Call Options Held

429K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $870M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.

Account

Rock Springs Capital Management LP Pacira Bio Sciences, Inc. Transaction History